EUVIMEDEUVIMED entdecken
Crossref

Liver Transplantation for Inherited Metabolic Disorders: A Work in Progress

V Sreekantam, K Kurkal iD, S Santra iD, V Suresh, J Raiman, L Johansen, P J Mckiernan, T Hutchin, K Sharif iD, C Kelgeri, G L Gupte

Acta Paediatrica · 2026-07 · 115 (7) · 1467-1473

DOI: 10.1111/apa.70512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 29.03.2026. Verfasst von V Sreekantam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inherited Metabolic Disease, Birmingham Children's Hospital, Birmingham, UK. Hauptthemen laut MEDLINE: Liver Transplantation, Metabolism, Inborn Errors. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To describe the trend of indications and outcomes of Liver transplant (LT) for Inherited Metabolic Disorders (IMD) in a single centre over 30 years.

Methods

A retrospective review of LT undertaken for IMD between 1989 to 2021 wasperformed. Demographic and clinical data, including LT indications, complications and outcomes, were collected. Categorical data were described as proportions; Kaplan–Meier analysis was used to determine patient/graft outcomes.

Results

55 patients (29 females) underwent 62 transplants between 1989 to 2021. Postoperative complications were rejection (17/62; 27.4%), bile leak (5/62; 8%), primary non‐function (4/62; 6.5%), hepatic artery thrombosis (6/62; 9.7%) and portal vein thrombosis (1/62; 1.6%). Mortality rate was highest in organic acidaemia (7/11 or 63.6%) in the 1st 2 decades of this period. Mortality was higher in the first decade of our LT program, which improved in subsequent decades. There was 53.3% mortality from 1989 to 2000; 18.8% from 2001 to 2010; and 8.3% from 2011 to 2021. Cumulative 1‐, 5‐, and 10‐year patient survival rates since 1989 were 78.1%,76.3%, 74.5%; graft survival rates were 69.3%,67.7% and 66.1%, respectively.

Conclusions

Although our overall patient and graft survival rates are lower than global reports, outcomes have improved in the last decade with careful patient and donor selection and changes in LT protocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationMetabolism, Inborn ErrorsHumansFemaleRetrospective StudiesMaleChildChild, PreschoolInfantPostoperative ComplicationsAdolescentTreatment Outcome

Stichwörter der Autor:innen

hepatic artery thrombosisinherited metabolic disordersliver transplantationmetabolic liver diseaseorganic acidaemia

Autor:innen und Institutionen

  • Department of Inherited Metabolic Disease, Birmingham Children's Hospital, Birmingham, UK.
  • Liver and Intestinal Transplant Unit, Birmingham Children's Hospital, Birmingham, UK.
  • Department of Newborn Screening and Biochemical Genetics, Birmingham Children's Hospital, Birmingham, UK.

ORCID-Profile: K Kurkal, S Santra, K Sharif

Zitieren

APA

Sreekantam, V., Kurkal, K., Santra, S., Suresh, V., Raiman, J., Johansen, L., Mckiernan, P. J., Hutchin, T., Sharif, K., Kelgeri, C., & Gupte, G. L. (2026). Liver Transplantation for Inherited Metabolic Disorders: A Work in Progress. Acta Paediatrica, 115(7), 1467-1473. https://doi.org/10.1111/apa.70512

Vancouver

Sreekantam V, Kurkal K, Santra S, Suresh V, Raiman J, Johansen L, et al. Liver Transplantation for Inherited Metabolic Disorders: A Work in Progress. Acta Paediatrica. 2026;115(7):1467-1473. doi:10.1111/apa.70512

BibTeX
@article{Sreekantam2026,
  author = {Sreekantam, V and Kurkal, K and Santra, S and Suresh, V and Raiman, J and Johansen, L and Mckiernan, P J and Hutchin, T and Sharif, K and Kelgeri, C and Gupte, G L},
  title = {Liver Transplantation for Inherited Metabolic Disorders: A Work in Progress},
  journal = {Acta Paediatrica},
  year = {2026},
  volume = {115},
  number = {7},
  pages = {1467--1473},
  doi = {10.1111/apa.70512}
}
Kostenlos starten →